1. Home
  2. ELUT vs MCHX Comparison

ELUT vs MCHX Comparison

Compare ELUT & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • MCHX
  • Stock Information
  • Founded
  • ELUT 2015
  • MCHX 2003
  • Country
  • ELUT United States
  • MCHX United States
  • Employees
  • ELUT N/A
  • MCHX N/A
  • Industry
  • ELUT Medical Specialities
  • MCHX Business Services
  • Sector
  • ELUT Health Care
  • MCHX Consumer Discretionary
  • Exchange
  • ELUT Nasdaq
  • MCHX Nasdaq
  • Market Cap
  • ELUT 73.2M
  • MCHX 84.3M
  • IPO Year
  • ELUT 2020
  • MCHX 2004
  • Fundamental
  • Price
  • ELUT $1.81
  • MCHX $1.92
  • Analyst Decision
  • ELUT Strong Buy
  • MCHX
  • Analyst Count
  • ELUT 2
  • MCHX 0
  • Target Price
  • ELUT $8.00
  • MCHX N/A
  • AVG Volume (30 Days)
  • ELUT 25.1K
  • MCHX 57.3K
  • Earning Date
  • ELUT 08-06-2025
  • MCHX 08-07-2025
  • Dividend Yield
  • ELUT N/A
  • MCHX N/A
  • EPS Growth
  • ELUT N/A
  • MCHX N/A
  • EPS
  • ELUT N/A
  • MCHX N/A
  • Revenue
  • ELUT $23,711,000.00
  • MCHX $47,951,000.00
  • Revenue This Year
  • ELUT $20.10
  • MCHX $5.73
  • Revenue Next Year
  • ELUT $85.89
  • MCHX N/A
  • P/E Ratio
  • ELUT N/A
  • MCHX N/A
  • Revenue Growth
  • ELUT N/A
  • MCHX N/A
  • 52 Week Low
  • ELUT $1.61
  • MCHX $1.26
  • 52 Week High
  • ELUT $5.24
  • MCHX $2.40
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 45.88
  • MCHX 60.79
  • Support Level
  • ELUT $1.72
  • MCHX $1.80
  • Resistance Level
  • ELUT $1.96
  • MCHX $1.92
  • Average True Range (ATR)
  • ELUT 0.15
  • MCHX 0.08
  • MACD
  • ELUT 0.01
  • MCHX 0.00
  • Stochastic Oscillator
  • ELUT 24.13
  • MCHX 80.00

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

Share on Social Networks: